Medical Research Commercialisation Fund III Overview
- Fund Strategy
-
Venture
- Fund Status
-
Closed
- Fund Manager
- Brandon Capital
- (You're viewing 1 of 2)
- Size
-
- Vintage
-
2015
- Dry Powder
-
Medical Research Commercialisation Fund III General Information
Description
Medical Research Commercialisation Fund III is a venture capital fund co-managed by Brandon Biocatalyst and Brandon Capital. The fund is located in Melbourne, Australia.
Contact Information
Fund Manager's Location
- Level 9
- 31 Queen Street
- Melbourne, Victoria 3000
- Australia
Medical Research Commercialisation Fund III Investments (17)
Medical Research Commercialisation Fund III has made a total of 17 investments. Its most recent deal was a with Ena Respiratory for . The deal was made on 15-Jun-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Ena Respiratory | 15-Jun-2021 | Drug Discovery | Clinical Trials - General | |||
| Longas | 23-Jan-2021 | Biotechnology | Generating Revenue | |||
| Azura Ophthalmics | 22-Oct-2020 | Drug Discovery | Clinical Trials - Phase 3 | |||
| EBR Systems | 04-Oct-2019 | Therapeutic Devices | Generating Revenue | |||
| Denteric | 26-Sep-2019 | Drug Discovery | Generating Revenue | |||
| Paragen Bio | 14-Aug-2018 | Biotechnology | Generating Revenue | |||
| Okogen | 27-Feb-2018 | Drug Discovery | Pre-Clinical Trials | |||
| QUE Oncology | 05-Jun-2017 | Drug Discovery | Pre-Clinical Trials | |||
| OncoRes Medical | 02-Jun-2017 | Early Stage VC (Series A) | Diagnostic Equipment | Pre-Clinical Trials | ||
| MetaBloQ | 08-Mar-2017 | Early Stage VC | Biotechnology | Startup |
Medical Research Commercialisation Fund III Investment Strategy
Medical Research Commercialisation Fund III Limited Partners (5)
AustralianSuper is one of Medical Research Commercialisation Fund III’s 5 limited partners. Its latest Original was on 20-Apr-2015.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| AustralianSuper | Current | 20-Apr-2015 | Original | ||
| HESTA Industry Super Fund | Current | 20-Apr-2015 | Original | ||
| Hostplus Superannuation Fund | Current | 20-Apr-2015 | Original | ||
| Hostplus Superannuation Fund | Current | 20-Apr-2015 | Secondary | ||
| Statewide Super | Corporate Pension | Former | 20-Apr-2015 | Original |
Medical Research Commercialisation Fund III Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
Medical Research Commercialisation Fund III Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Medical Research Commercialisation Fund III Benchmark (43)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| MEVP Impact Fund | |||||
| Wamda MENA Ventures I | |||||
| Magma Venture Capital IV | |||||
| EWA Fund I | |||||
| Apoletto Investments V | |||||
| Glilot Capital Partners II | 31-Dec-2022 | ||||
| The TankStream Ventures Fund | 31-Dec-2022 | ||||
| Ibtikar Fund | |||||
| Genesis Partners V | |||||
| Berytech Fund II |
Medical Research Commercialisation Fund III FAQs
-
What is Medical Research Commercialisation Fund III?
Medical Research Commercialisation Fund III is a venture capital fund co-managed by Brandon Biocatalyst and Brandon Capital.
-
Who manages Medical Research Commercialisation Fund III?
Medical Research Commercialisation Fund III is managed by Brandon Capital and Brandon Biocatalyst.
-
Where is Medical Research Commercialisation Fund III domiciled?
Medical Research Commercialisation Fund III is domiciled in Australia.
-
What is Medical Research Commercialisation Fund III's size?
Medical Research Commercialisation Fund III has a size of .
-
What type of fund is Medical Research Commercialisation Fund III?
The fund type of Medical Research Commercialisation Fund III is Venture.
-
What is the status of Medical Research Commercialisation Fund III?
Medical Research Commercialisation Fund III is closed.
-
What has Medical Research Commercialisation Fund III invested in?
Medical Research Commercialisation Fund III has made numerous investments in companies like Ena Respiratory, Longas, and Azura Ophthalmics within the Drug Discovery and Biotechnology industries.
-
What has Medical Research Commercialisation Fund III invested in recently?
Medical Research Commercialisation Fund III's latest investment was on 15-Jun-2021 in Ena Respiratory, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process